Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Hooi C. Ee is active.

Publication


Featured researches published by Hooi C. Ee.


The American Journal of Gastroenterology | 2010

A Cohort Study of Missed and New Cancers After Esophagogastroduodenoscopy

Spiro C. Raftopoulos; Dev S. Segarajasingam; Valerie Burke; Hooi C. Ee; Ian F. Yusoff

OBJECTIVES:Little is known about missed rates of upper gastrointestinal cancer (UGC) in Western populations, with most data originating from Japanese centers quoting high missed rates of 23.5–25.8%. The objective of this study was to better define missed rates of esophagogastroduodenoscopy (EGD) and the natural history of UGC in a Western population that underwent an initial EGD without cancer, but were subsequently diagnosed with a UGC. Our hypothesis was that a normal EGD rarely misses the detection of UGC.METHODS:This is a retrospective cohort study. A prospectively maintained electronic database was used to identify all patients who underwent EGD between 1990 and 2004 at the study institution. Patients in this cohort who were diagnosed with UGC before 2006 were identified through the Western Australian Cancer Registry. We defined missed cancers as those diagnosed within 1 year of EGD, possible missed cancers as those diagnosed 1–3 years after EGD, and new cancers as those diagnosed more than 3 years after EGD. This study had no interventions and was conducted at a tertiary referral center. The main outcome measurement included UGC.RESULTS:Of the 28,064 EGDs performed, UGC was diagnosed subsequent to the procedure in 116 cases (0.41%). There were 29 missed cancers, 26 possible missed cancers, and 75 new cancers. Of the missed cancers, 11 were esophageal, 15 were gastric, and 3 were duodenal. In 69% (n=20) of the missed cancers, an abnormality was described at the site of malignancy. In 59% (n=17) of the missed cancers, the indication for EGD was an alarm symptom of dysphagia or suspected blood loss. In an univariate analysis, the presence of an alarm symptom was related to missed cancers, whereas operator experience, trainee participation, and usage of newer equipment were not. One of the main limitations of this study is that it was a retrospective review.CONCLUSIONS:UGC is rare after normal EGD, confirming the high accuracy of EGD. Institutional approval was granted for the conduct of this study.


Clinical Nuclear Medicine | 2013

Detection of hypoxia with 18F-fluoromisonidazole (18F-FMISO) PET/CT in suspected or proven pancreatic cancer.

Tatiana Segard; Peter Robins; Ian F. Yusoff; Hooi C. Ee; Laurence Morandeau; Elaine M. Campbell; Roslyn J. Francis

Purpose of the Report Pancreatic carcinoma is known to demonstrate molecular features of hypoxia. The aim of this prospective pilot study is to analyze the hypoxia agent fluoromisonidazole (FMISO) using PET/CT in pancreatic carcinoma and to compare FMISO activity with glucose metabolism reflected by FDG. Patients and Methods Ten patients with pancreatic carcinoma underwent FMISO and FDG PET scans. FMISO and FDG PET/CT scans were analyzed by 2 PET physicians. Regions of interest drawn on the FDG images were transposed to the FMISO images after study coregistration. The FDG SUVmax was used to quantify metabolic activity and FMISO SUVmax and tumor-to-background (muscle) ratio to quantify hypoxia. Results Seven patients were diagnosed with pancreatic adenocarcinoma. The remaining patients had a neuroendocrine tumor, poorly differentiated/sarcomatoid carcinoma, and mucinous neoplasm. Visual analysis demonstrated increased FMISO activity in 2 pancreatic adenocarcinomas. All patients, however, had increased FDG activity at the tumor site. Mean FDG SUVmax was 6 (range: 3.8 to 9.5) compared to 2.3 for FMISO (range: 1 to 3.4). The 2 positive studies on visual analysis of FMISO did not correspond to the largest tumors, the studies with the highest FMISO or FDG SUVmax. There was no significant correlation between FMISO and FDG SUVmax values. Conclusions The hypoxia imaging agent, FMISO, demonstrates minimal activity in pancreatic tumors. If FMISO PET/CT is to be included in clinical trial protocols of hypoxia in pancreatic cancer, it would require correlation with other imaging modalities to localize the tumor and allow semiquantitative analysis.


The Medical Journal of Australia | 2018

Revised Australian national guidelines for colorectal cancer screening: family history

Mark A. Jenkins; Driss Ait Ouakrim; Alex Boussioutas; John L. Hopper; Hooi C. Ee; Jon Emery; Finlay Macrae; Albert Chetcuti; Laura Wuellner; D. James B. St. John

Introduction: Screening is an effective means for colorectal cancer prevention and early detection. Family history is strongly associated with colorectal cancer risk. We describe the rationale, evidence and recommendations for colorectal cancer screening by family history for people without a genetic syndrome, as reported in the 2017 revised Australian guidelines.


The American Journal of Surgical Pathology | 2017

Neoplastic Lesions of Gastric Adenocarcinoma and Proximal Polyposis Syndrome (GAPPS) are Gastric Phenotype

Willem Bastiaan de Boer; Hooi C. Ee; Marian Priyanthi Kumarasinghe

Neoplastic lesions of gastric adenocarcinoma and proximal polyposis of the stomach (GAPPS) are gastric phenotype. GAPPS was reported in 2011 as a new autosomal dominant gastric polyposis syndrome characterized by involvement of the gastric body/fundus with sparing of the antrum by multiple polyps, reported to be primarily fundic gland polyps (FGPs), with progression to dysplasia and adenocarcinoma of intestinal type. Our series consists of 51 endoscopic biopsies and 5 gastrectomy specimens from 25 patients belonging to a previously defined GAPPS family. Slides were reviewed and further stains performed. Endoscopy was abnormal in 15 of the 25 patients: carpeting polyposis of the gastric body and fundus in 14 and a gastric mass without polyposis in one. The most common polypoid lesion (seen in 12 patients) was a disorganized proliferation of specialized/oxyntic glands high up in the mucosa involving the attenuated foveolar region around the gastric pits, which we have termed “hyperproliferative aberrant pits”. Well developed FGP were seen in 10 patients. Established neoplastic lesions seen in 9 patients were: (1) discrete gastric adenomas, (2) multifocal “flat” dysplasia in the setting of hyperproliferative aberrant pits +/− FGPs, (3) adenomatous tissue associated with adenocarcinoma. All cases of dysplasia were of gastric phenotype based on morphology and mucin immunohistochemistry. In conclusion: (1) the spectrum of gastric pathology associated with GAPPS is wider than previously reported, (2) the earliest microscopic clue is the finding of hyperproliferative aberrant pits, and (3) the dysplasia is gastric phenotype and the subsequent adenocarcinoma may follow the gastric pathway of carcinogenesis.


Gastroenterology | 2011

A Population Based Study of Gastric Dysplasia in a Western Population

Spiro C. Raftopoulos; Marian Priyanthi Kumarasinghe; W.B. De Boer; Jean Iacobelli; N. Kontorinis; Soraya Fermoyle; John K. Olynyk; Cynthia H. Forrest; Hooi C. Ee; Ian F. Yusoff

higher in GC tissue, but lower in plasma than those of CSG; and they restored towards normal in plasma after surgery removal. GC/TOFMS data was analyzed using principal component analysis (PCA), partial least squares projection to latent structures and discriminant analysis (PLS-DA).An overview of the data set produced with PCA showed the complete separation of the tissue samples and plasma samples (Figure S-2a). The tissue samples showed larger variations between the GC and CSG patients than did the plasma samples (Figure S-2b). To characterize the metabolic phenotypes of the GC plasma and the postoperative GC plasma relative to the CSG plasma control, a PLS-DA model was calculated (Figure S-2c). CONCLUSION: In tissue of the GC patients, amino acids turn-over, glycolysis, lipid and TCA metabolism were up-regulated while the intermediates level were lower in plasma of GC patients than those in CSG. Surgery removal of GC tissue restored the metabolites level towards normal. The metabolites involved in above metabolism were suggested as the potential markers of GC and had the potential to be alternative diagnostic indicators.


Gastrointestinal Endoscopy | 2002

Complete colonoscopy rarely misses cancer.

Hooi C. Ee; James B. Semmens; Neville E. Hoffman


The Medical Journal of Australia | 2002

Colonoscopic surveillance for family history of colorectal cancer: are NHMRC guidelines being followed?

Ian F. Yusoff; Neville Hoffman; Hooi C. Ee


Gastrointestinal Endoscopy | 2006

Repeat colonoscopy has a low yield even in symptomatic patients

Cynthia H. Seow; Hooi C. Ee; Alex B. Willson; Ian F. Yusoff


The Medical Journal of Australia | 2007

Will promoting general practitioners with special interests threaten access to primary care

Moyez Jiwa; Hooi C. Ee; Justin Beilby


Anz Journal of Surgery | 2005

COLONOSCOPIC SURVEILLANCE AFTER CURATIVE SURGERY FOR COLORECTAL CANCER

Hooi C. Ee; Ian F. Yusoff

Collaboration


Dive into the Hooi C. Ee's collaboration.

Top Co-Authors

Avatar

Ian F. Yusoff

University of Western Australia

View shared research outputs
Top Co-Authors

Avatar

Dev S. Segarajasingam

Sir Charles Gairdner Hospital

View shared research outputs
Top Co-Authors

Avatar

Spiro C. Raftopoulos

Sir Charles Gairdner Hospital

View shared research outputs
Top Co-Authors

Avatar

Alma Fulurija

University of Western Australia

View shared research outputs
Top Co-Authors

Avatar

Barry J. Marshall

University of Western Australia

View shared research outputs
Top Co-Authors

Avatar

Laurence Morandeau

Sir Charles Gairdner Hospital

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Neville Hoffman

Sir Charles Gairdner Hospital

View shared research outputs
Top Co-Authors

Avatar

Peter Robins

Sir Charles Gairdner Hospital

View shared research outputs
Top Co-Authors

Avatar

Roslyn J. Francis

Sir Charles Gairdner Hospital

View shared research outputs
Researchain Logo
Decentralizing Knowledge